Blackhawk Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Blackhawk Capital Partners's AMGN Position: Q2 2020 in Review
Blackhawk Capital Partners sold out of Amgen (AMGN) in Q2 2020, closing a stake of 5,987 shares — an estimated $1.44M sold.
Blackhawk Capital Partners first reported a position in AMGN in Q4 2017 and held it in 10 quarters. The position peaked at $1.44M in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.
- Blackhawk Capital Partners reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
- Blackhawk Capital Partners sold 5,987 Amgen shares in Q2 2020, an estimated $1.44M.
- Blackhawk Capital Partners first reported a position in Amgen in Q4 2017 and held it in 10 quarters.
- Blackhawk Capital Partners's Amgen position peaked at $1.44M in Q1 2020.
- 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.
Based on Blackhawk Capital Partners's 13F filing for Q2 2020, filed 4 Aug 2020.